# Safety and Tolerability Study of a Novel Bioartificial Liver in Liver Failure and Small-for-Size Syndrome

> **NCT07312864** · PHASE1,PHASE2 · RECRUITING · sponsor: **Beijing Friendship Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Liver Failure
- Small-for-Size Syndrome

## Interventions

- **BIOLOGICAL:** Chemically induced pluripotent stem cells biological Artificial Liver

## Key facts

- **NCT ID:** NCT07312864
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07312864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07312864, "Safety and Tolerability Study of a Novel Bioartificial Liver in Liver Failure and Small-for-Size Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07312864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*